Why the study?
Pharmacodynamic responsiveness and platelet reactivity recovery vary after discontinuation of P2Y12 receptor inhibitors.
Does preoperative platelet function testing improve individualized discontinuation and targeted postpump hemostatic management in patients on antiplatelet therapy before cardiac surgery?
Does preoperative platelet function testing improve individualized discontinuation and targeted postpump hemostatic management in patients on antiplatelet therapy before cardiac surgery?
Preoperative platelet function testing may help individualize the discontinuation of P2Y12 inhibitors and guide post-bypass hemostatic management in cardiac surgery patients.
Hypothesis-generating for platelet testing to guide P2Y12 discontinuation; prospective trials needed before transfusion algorithm integration.
Based on variable pharmacodynamic responsiveness and platelet reactivity recovery after discontinuation of P2Y12 receptor inhibitors, preoperative platelet function testing may individualize discontinuation and be a part of transfusion algorithm triggering targeted postpump hemostatic management.
No takes yet. Share an insight, caveat, or question.
Mahla et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: